A "mouse hospital" for preclinical testing of diagnostic and treatment modalities in pancreatic ductal adenocarcinoma (PDA)

被引：0
|
作者：
Clendenin, Cynthia [1 ]
Sor, Rina [1 ]
McMenamin, Deirdre [1 ]
Stanger, Ben Z. [1 ]
Beatty, Gregory [1 ]
Vonderheide, Robert H. [1 ]
机构：
[1] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 24期
关键词：
D O I：
10.1158/1538-7445.PANCA19-C13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C13
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Multimodal treatment of resectable pancreatic ductal adenocarcinoma
    Silvestris, Nicola
    Brunetti, Oronzo
    Vasile, Enrico
    Cellini, Francesco
    Cataldo, Ivana
    Pusceddu, Valeria
    Cattaneo, Monica
    Partelli, Stefano
    Scartozzi, Mario
    Aprile, Giuseppe
    Gardini, Andrea Casadei
    Morganti, Alessio Giuseppe
    Valentini, Vincenzo
    Scarpa, Aldo
    Falconi, Massimo
    Calabrese, Angela
    Lorusso, Vito
    Reni, Michele
    Cascinu, Stefano
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 111 : 152 - 165
  • [32] Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
    Norihiro Sato
    Xiao-Bo Cheng
    Shiro Kohi
    Atsuhiro Koga
    Keiji Hirata
    ActaPharmaceuticaSinicaB, 2016, 6 (02) : 101 - 105
  • [33] Preclinical systems to study the biodistribution of nanoparticle delivery in pancreatic ductal adenocarcinoma
    Collisson, Eric A.
    Zuckerman, Jonathan
    Wang, Donghui
    Phojanakong, Paul
    Gale, Aaron B.
    Choi, Chung Hang J.
    Hann, Byron
    McCormick, Frank
    Davis, Mark
    CANCER RESEARCH, 2012, 72
  • [34] Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
    Sato, Norihiro
    Cheng, Xiao-Bo
    Kohi, Shiro
    Koga, Atsuhiro
    Hirata, Keiji
    ACTA PHARMACEUTICA SINICA B, 2016, 6 (02) : 101 - 105
  • [35] Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma
    Silvestris, Nicola
    Longo, Vito
    Cellini, Francesco
    Reni, Michele
    Bittoni, Alessandro
    Cataldo, Ivana
    Partelli, Stefano
    Falconi, Massimo
    Scarpa, Aldo
    Brunetti, Oronzo
    Lorusso, Vito
    Santini, Daniele
    Morganti, Alessio
    Valentini, Vincenzo
    Cascinu, Stefano
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 98 : 309 - 324
  • [36] Targeting translation for the treatment of pancreatic ductal adenocarcinoma
    Safari, Maryam
    Kim, Yu Ri
    Mundi, Prabhjot S.
    Deng, Changchun
    Bates, Susan E.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [37] PET/CT imaging of pancreatic ductal adenocarcinoma with a claudin-4 binding peptide in preclinical mouse model
    Seo, Jai Woong
    Wang, James
    Kare, Aris J.
    Tumbale, Spencer K.
    Wu, Bo
    Raie, Marina N.
    Pandrala, Mallesh
    Ferrara, Katherine W.
    CANCER RESEARCH, 2024, 84 (06)
  • [38] Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma
    Azmi, Asfar S.
    Khan, Husain Yar
    Muqbil, Irfana
    Aboukameel, Amro
    Neggers, Jasper E.
    Daelemans, Dirk
    Mahipal, Amit
    Dyson, Gregory
    Kamgar, Mandana
    Al-Hallak, Mohammad Najeeb
    Tesfaye, Anteneh
    Kim, Steve
    Shidham, Vinod
    Mohammad, Ramzi M.
    Philip, Philip A.
    CLINICAL CANCER RESEARCH, 2020, 26 (06) : 1338 - 1348
  • [39] The microbiome as a potential diagnostic biomarker for pancreatic ductal adenocarcinoma (PDAC)
    Wheatley, Roseanna C.
    Valle, Juan W.
    McNamara, Mairead G.
    HEPATOBILIARY SURGERY AND NUTRITION, 2022,
  • [40] Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma
    Chung, Kwang Hyun
    Lee, Jong-Chan
    Lee, Jongchan
    Cho, In-Kuk
    Kim, Jaihwan
    Jang, Woncheol
    Yoo, Byong Chul
    Hwang, Jin-Hyeok
    PANCREATOLOGY, 2020, 20 (07) : 1465 - 1471
12345